Foghorn Therapeutics Provides Corporate Update

NEXT STORY
Global RNA-based Therapeutics and Vaccines Market Trajectory & Analytics Report 2021-2027
PREV STORY
Myovant Sciences Announces Corporate Updates and Financial Results for Fourth Fiscal Quarter and Fiscal Year Ended March 31, 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Summit Therapeutics plc : Interim 24-Week Data from PhaseOut DMD

Summit Therapeutics plc('Summit', or 'the Company') EZUTROMID SIGNIFICANTLY REDUCED MUSCLE DAMAGE IN DMD PATIENTS ...

author_avatar
NASDAQ Market News

BeiGene to Present at the Cowen and Company 37th Annual Health Care Conference

CAMBRIDGE, Mass., Feb. 27, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News

Clearside Biomedical, Inc. to Present at the 2016 Ladenburg Thalmann Healthcare Conference

ALPHARETTA, Ga., Sept. 20, 2016 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage ...

author_avatar
NASDAQ Market News